SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 21, 2001
ARQULE, INC.
(Exact Name of Issuer as Specified in Charter)
Delaware 000-21429 04-3221586
-------------- ------------ ----------------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
19 Presidential Way
Woburn, MA
-------------------
(Address of principal executive offices)
01801
-----
(Zip code)
(781) 994-0300
--------------
(Registrant's telephone number, including area code)
Item 5. Other Events
On December 20, 2001, ArQule, Inc. entered into a significant expansion
and extension of its strategic alliance with Pfizer, Inc, originally established
in 1999. A press release describing the terms of the extension is included as an
exhibit to this report and is incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
99.1 Text of Press Release, dated December 21, 2001.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ARQULE, INC.
(Registrant)
/s/ Stephen A. Hill
-----------------------------------
Stephen A. Hill
President and Chief Executive Officer
Date: December 21, 2001